PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...
Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...
The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback